CRP and non-small cell lung carcinoma: CRP values were significantly lower in NSCLC patients with PD-L1 mutations than in those without PD-L1 mutations (22.7 [IQR: 10.4; 40.3] vs. 76.7 [IQR: 32.6; 140] mg/L, p = 0.029) (Figure 1).